Certara

What it does

Certara is a biosimulation and regulatory science company that uses AI and pharmacokinetic/pharmacodynamic (PK/PD) modeling to accelerate drug development decisions and support FDA regulatory submissions. Its platform includes Phoenix for PK/PD modeling and simulation, Simcyp for physiologically-based pharmacokinetic (PBPK) simulation, and D360 for integrated drug discovery data management. AI capabilities include machine learning models that predict drug behavior in the body from molecular structure, AI-powered regulatory intelligence that identifies the optimal clinical trial design and dosing strategy based on modeling, automated population PK analysis, and natural language processing tools that help scientists navigate the regulatory submission landscape. Certara is used by major pharmaceutical companies, biotech firms, and regulatory agencies to reduce the number of clinical trials needed and increase submission approval rates.

Strengths

• Large pharmaceutical companies and biotech firms use Certara for biosimulation-based drug development - AI and PK/PD modeling reducing clinical trial requirements, informing dosing decisions, and supporting FDA submissions with quantitative evidence.
• Certara is a biosimulation and regulatory science company that uses AI and pharmacokinetic/pharmacodynamic (PK/PD) modeling to accelerate drug development decisions and support FDA regulatory submissions.
• Its platform includes Phoenix for PK/PD modeling and simulation, Simcyp for physiologically-based pharmacokinetic (PBPK) simulation, and D360 for integrated drug discovery data management.

Watch-outs

• Highly specialized domain expertise required: Certara's biosimulation and PK/PD modeling platforms require specialized pharmacokineticists and clinical pharmacologists to build and interpret models — the AI augments domain experts rather than enabling non-specialists to perform biosimulation.
• Life sciences drug development vertical only: Certara's platform is built for pharmaceutical drug development — medical device companies, diagnostics, and non-pharma life sciences have limited applicable use cases.
• Enterprise pricing for pharmaceutical clients: Certara's platform is priced for pharmaceutical industry clients with large R&D budgets — small biotechs and academic researchers often access Certara through academic licensing or specific project consulting rather than enterprise subscriptions.

Pricing

Certara enterprise contracts not published. Platform subscriptions and consulting services priced separately. Pharmaceutical enterprise contracts run millions annually. Academic and small biotech licensing available.